BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1543361)

  • 1. [Serum sialyl-Tn antigen in colorectal cancer and its relationship to prognosis].
    Yamaguchi A; Tukioka Y; Fushida S; Kurosaka Y; Kanno M; Yonemura Y; Miwa K; Miyazaki I
    Gan To Kagaku Ryoho; 1992 Mar; 19(3):349-53. PubMed ID: 1543361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of sialyl Lewis(a), sialyl Lewis(x), and sialyl Tn antigens expression levels as predictors of recurrence after curative surgery in node-negative colorectal cancer patients.
    Nakagoe T; Fukushima K; Tanaka K; Sawai T; Tsuji T; Jibiki M; Nanashima A; Yamaguchi H; Yasutake T; Ayabe H; Arisawa K
    J Exp Clin Cancer Res; 2002 Mar; 21(1):107-13. PubMed ID: 12071515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sialyl Tn antigen expression is associated with the prognosis of patients with advanced colorectal cancer.
    Imada T; Rino Y; Hatori S; Takahashi M; Amano T; Kondo J; Suda T
    Hepatogastroenterology; 1999; 46(25):208-14. PubMed ID: 10228794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative serum levels of sialyl Lewis(a), sialyl Lewis(x), and sialyl Tn antigens as prognostic markers after curative resection for colorectal cancer.
    Nakagoe T; Sawai T; Tsuji T; Jibiki MA; Nanashima A; Yamaguchi H; Yasutake T; Kurosaki N; Ayabe H; Arisawa K
    Cancer Detect Prev; 2001; 25(3):299-308. PubMed ID: 11425272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in prognosis of colorectal cancer patients based on the expression of sialyl Lewisa, sialyl Lewisx and sialyl Tn antigens in serum and tumor tissue.
    Akamine S; Nakagoe T; Sawai T; Tsuji T; Tanaka K; Hidaka S; Shibasaki S; Nanashima A; Yamaguchi H; Nagayasu T; Yasutake T
    Anticancer Res; 2004; 24(4):2541-6. PubMed ID: 15330211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical usefulness of serum CYFRA21-1 in colorectal cancer].
    Miyashita T; Nishimura G; Michiwa Y; Sato T; Tsugawa K; Fushida S; Sugiyama K; Fujimura T; Yonemura Y; Miwa K; Miyazaki I
    Gan To Kagaku Ryoho; 1996 Oct; 23(12):1693-6. PubMed ID: 8886047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical significance of serum sialyl Tn antigen in patients with gynecological cancer. STN Study Group].
    Noda K; Shiota M; Tanizawa O; Inoue M; Tenjin Y; Sugishita T; Yakushiji M; Miyoshi T; Nozawa S; Sakuma T
    Gan To Kagaku Ryoho; 1991 Jul; 18(8):1287-96. PubMed ID: 2069400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serological studies on CEA, CA 19-9, STn and SLX in colorectal cancer.
    Sato T; Nishimura G; Nonomura A; Miwa K; Miyazaki I
    Hepatogastroenterology; 1999; 46(26):914-9. PubMed ID: 10370638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serum sialyl Tn antigen as a prognostic marker in patients with epithelial ovarian cancer].
    Kobayashi H; Terao T; Kawashima Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1992 Jan; 44(1):14-20. PubMed ID: 1541859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-associated antigen recognized by the 22-1-1 monoclonal antibody encourages colorectal cancer progression under the scanty CD8+ T cells.
    Oshikiri T; Miyamoto M; Morita T; Fujita M; Miyasaka Y; Senmaru N; Yamada H; Takahashi T; Horita S; Kondo S
    Clin Cancer Res; 2006 Jan; 12(2):411-6. PubMed ID: 16428480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative serum level of CA19-9 predicts recurrence after curative surgery in node-negative colorectal cancer patients.
    Nakagoe T; Sawai T; Tsuji T; Jibiki MA; Nanashima A; Yamaguchi H; Yasutake T; Ayabe H; Arisawa K
    Hepatogastroenterology; 2003; 50(51):696-9. PubMed ID: 12828063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of circulating sialyl Tn antigen in colorectal cancer patients.
    Nakagoe T; Sawai T; Tsuji T; Jibiki M; Nanashima A; Yamaguchi H; Kurosaki N; Yasutake T; Ayabe H; Tagawa Y
    Anticancer Res; 2000; 20(5C):3863-9. PubMed ID: 11268468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical value of sialyl Tn antigen in patients with gynecologic tumors.
    Inoue M; Ogawa H; Nakanishi K; Tanizawa O; Karino K; Endo J
    Obstet Gynecol; 1990 Jun; 75(6):1032-6. PubMed ID: 2342728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer cell morphology at the invasive front and expression of cell adhesion-related carbohydrate in the primary lesion of patients with colorectal carcinoma with liver metastasis.
    Ono M; Sakamoto M; Ino Y; Moriya Y; Sugihara K; Muto T; Hirohashi S
    Cancer; 1996 Sep; 78(6):1179-86. PubMed ID: 8826938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-operative serum levels of sialyl Tn antigen predict liver metastasis and poor prognosis in patients with gastric cancer.
    Nakagoe T; Sawai T; Tsuji T; Jibiki M; Nanashima A; Yamaguchi H; Yasutake T; Ayabe H; Arisawa K; Ishikawa H
    Eur J Surg Oncol; 2001 Dec; 27(8):731-9. PubMed ID: 11735169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of CEA, TPA, GICA, CA 72.4, and CA 195 in the Diagnosis of primary colorectal cancer and at its relapse.
    Nicolini A; Caciagli M; Zampieri F; Ciampalini G; Carpi A; Spisni R; Colizzi C
    Cancer Detect Prev; 1995; 19(2):183-95. PubMed ID: 7750106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
    Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
    Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The significance of anti-sialyl-Tn antibodies in patients with colorectal and breast cancer.
    Coomber DW; Hawkins NJ; Dalley D; Ward RL
    Neoplasma; 1998; 45(1):12-6. PubMed ID: 9604995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The possible approaches to prognosis in colorectal cancer].
    Teploukhova IM; Vvedenskaia NA; Papish EA
    Vopr Onkol; 1991; 37(6):651-6. PubMed ID: 1843140
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical significance of serum NCC-ST 439 as a tumor marker for colorectal cancer].
    Yamaguchi A; Kurosaka Y; Ohta N; Kamata T; Ishida T; Nishimura G; Katoh M; Kosaka T; Yonemura Y; Miyazaki I
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2645-50. PubMed ID: 2549882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.